Cambridge, MA, United States of America

Pablo Argüeso

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The Schepens Eye Research Institute, Inc.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pablo Argüeso. Retrieved from https://idiyas.com/inventor/pablo-argüeso

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Pablo Argüeso

Introduction

Pablo Argüeso is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biomedical research, particularly in the area of anti-inflammatory agents. His work is recognized for its potential impact on therapeutic applications.

Latest Patents

Pablo Argüeso holds a patent for "Endomucin as an anti-inflammatory agent." This invention provides compositions and methods for utilizing endomucin as an anti-inflammatory agent. His innovative approach aims to address inflammation-related conditions effectively. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Argüeso is affiliated with The Schepens Eye Research Institute, Inc., where he conducts research that bridges the gap between laboratory findings and clinical applications. His work at this esteemed institution highlights his dedication to improving patient outcomes through scientific innovation.

Collaborations

Throughout his career, Pablo has collaborated with esteemed colleagues, including Patricia A D'Amore and Alisar S Zahr. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Pablo Argüeso's contributions to the field of anti-inflammatory research exemplify the importance of innovation in medicine. His patent on endomucin reflects his dedication to finding solutions for complex health issues. Through his work, he continues to inspire future advancements in biomedical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…